We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Laser Ablation in Liver Tumors

By HospiMedica staff writers
Posted on 21 Dec 2005
A 12-year study has found that laser ablation with magnetic resonance (MR) guidance is as effective as traditional surgery in the treatment of liver tumors in some patients.

In the largest study of its type and with the longest follow-up, 839 patients at the University of Frankfurt (Frankfurt, Germany) received MR-guided laser-induced thermotherapy (LITT), also known as laser ablation, to destroy tumor tissue. More...
The average survival rate from the date of diagnosis was 3.8 years, which compares favorably to survival rates after traditional surgery (approximately 1.5-5.0 years).

Laser ablation can be used to treat tumors that occur in both halves of the liver--often during the same treatment--which is practically impossible in traditional surgery where typically only the left or right lobe is resected. If new tumors are found during follow-up exams, it is much easier to repeat laser treatment than to subject the patient to another open surgery.

Laser treatment can be done on an outpatient basis under local anesthesia. Typically, the patient stays only several hours, instead of several weeks in the hospital after surgical liver resection

"Many surgeons are already performing local ablation instead of resection, because they have already recognized the positive effect of local ablation,” said the study's lead author, Dr. Martin Mack, an associate professor in the department of diagnostic and interventional radiology at the University of Frankfurt. "I believe that minimally invasive tumor ablation together with chemotherapy will play the most important role in the treatment of tumors in the years to come.”




Related Links:
University of Frankfurt

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Patient Preoperative Skin Preparation
BD ChloraPrep
New
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.